Department of Biochemistry and Molecular Biology, University of Louisville, Louisville, KY, 40206, USA.
James Graham Brown Cancer Center, University of Louisville, Louisville, KY, 40206, USA; Department of Biochemistry and Molecular Biology, University of Louisville, Louisville, KY, 40206, USA; Department of Medicine, University of Louisville, Louisville, KY, 40206, USA.
Biochimie. 2018 Sep;152:134-148. doi: 10.1016/j.biochi.2018.06.024. Epub 2018 Jun 30.
Over the past two decades biologists and bioinformaticians have unearthed substantial evidence supporting a role for G-quadruplexes as important mediators of biological processes. This includes telomere damage signaling, transcriptional activity, and splicing. Both their structural heterogeneity and their abundance in oncogene promoters makes them ideal targets for drug discovery. Currently, there are hundreds of deposited DNA and RNA quadruplex atomic structures which have allowed researchers to begin using in silico drug screening approaches to develop novel stabilizing ligands. Here we provide a review of the past decade of G-quadruplex virtual drug discovery approaches and campaigns. With this we introduce relevant virtual screening platforms followed by a discussion of best practices to assist future G4 VS campaigns.
在过去的二十年中,生物学家和生物信息学家已经挖掘出大量证据,支持 G-四链体在生物学过程中作为重要介质的作用。这包括端粒损伤信号、转录活性和剪接。它们的结构异质性及其在致癌基因启动子中的丰富程度,使它们成为药物发现的理想目标。目前,已经有数百个 DNA 和 RNA 四链体的原子结构被储存,这使得研究人员能够开始使用计算机药物筛选方法来开发新型稳定配体。在这里,我们回顾了过去十年的 G-四链体虚拟药物发现方法和活动。通过这一点,我们介绍了相关的虚拟筛选平台,然后讨论了最佳实践,以协助未来的 G4 VS 活动。